Get App Open
In App
Credit Cards
Open App
you are here:

Kilitch Drugs (India) Ltd.

BSE: 524500 | NSE: KILITCH |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE729D01010 | SECTOR: Pharmaceuticals & Drugs

BSE Live

Oct 31, 16:01
390.55 8.80 (2.31%)
Volume
AVERAGE VOLUME
5-Day
9,876
10-Day
5,985
30-Day
3,204
583
  • Prev. Close

    381.75

  • Open Price

    388.30

  • Bid Price (Qty.)

    375.25 (50)

  • Offer Price (Qty.)

    398.95 (50)

NSE Live

Oct 31, 15:40
388.35 4.05 (1.05%)
Volume
AVERAGE VOLUME
5-Day
148,429
10-Day
87,477
30-Day
35,156
19,027
  • Prev. Close

    384.30

  • Open Price

    387.35

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    388.35 (30)

Company History - Kilitch Drugs (India)
 M/s Kilitch Drugs (India) ltd was incorporated on 12th May, 1992 with
 the Registrar of Companies, Maharashtra at Bombay as a public limited
 company and obtained certificate for commencement of business dated
 26-05-92. The company went Public in February 1994 for setting up a
 pharmaceutical formulation plant to manufacture pharmaceutical
 products in the form of tablets, capsules, liquid orals, ointments,
 creams and injectables. The company could not commence its
 manufacturing activities as planned in the Public Issue on account of
 delay in completion of building. Till date, the company has not
 commenced any manufacturing activities. The land and building is now
 completed and in order to have the benefit of its capacity, the
 company is planning this rights issue for expanding its injectable
 capacity from 30,000 ltrs. to 75,000 Itrs.
 
 Due to delay in implementation of project, the company could not come
 out with its own production till date and therefore the company is
 presently trading in pharmaceutical formulations like tablets,
 capsules, liquid orals, ointments, creams and injectables. The
 trading turnover of the company for the year 1994-95 was Rs.550.50
 Lacs.
 
 
 2008
 
 -Board recommends final dividend of 10%.
 
 2009
 
 -The Company got a GOLD AWARD for Quality Excellence.
 
 
 2010
 
 -Listing of Equity Shares at NSE.
 
 2011
 
 2015
 
 -Kilitch Drugs entered joint venture with local firm in Ethopia 
 
 2021
 
 -Kilitch Drugs starts production of Cephalosporins Injectables at
 Ethiopia Plant' dated 26th July 2021. 
 
Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347